Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
CALL
Funko
FNKO
$341M
| $1.43M | ﹤0.01% |
63,900
+12,100
| +23% | +$234K |
|
6127
CALL
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
| $1.43M | ﹤0.01% |
+33,400
| New | +$1.52M |
|
6128
CALL
TaskUs
TASK
$659M
| $1.43M | ﹤0.01% |
84,600
-127,800
| -60% | -$3.26M |
|
6129
CALL
NETSCOUT
NTCT
$2.85B
| $1.43M | ﹤0.01% |
42,100
+29,500
| +234% | +$990K |
|
6130
CALL
Replimune Group
REPL
$1.37B
| $1.43M | ﹤0.01% |
81,500
+68,600
| +532% | +$1.13M |
|
6131
PUT
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $1.43M | ﹤0.01% |
+29,800
| New | +$1.44M |
|
6132
Rogers Corp
ROG
$2.61B
| $1.42M | ﹤0.01% |
5,432
-7,086
| -57% | -$1.88M |
|
6133
PUT
Century Communities
CCS
$2B
| $1.42M | ﹤0.01% |
31,600
-1,700
| -5% | -$85.9K |
|
6134
CALL
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $1.42M | ﹤0.01% |
64,000
-28,300
| -31% | -$614K |
|
6135
CALL
National Fuel Gas
NFG
$7.78B
| $1.42M | ﹤0.01% |
21,500
+9,900
| +85% | +$694K |
|
6136
CALL
Nurix Therapeutics
NRIX
$2.82B
| $1.42M | ﹤0.01% |
112,100
+25,000
| +29% | +$283K |
|
6137
Cass Information Systems
CASS
$733M
| $1.42M | ﹤0.01% |
41,977
-2,212
| -5% | -$79.4K |
|
6138
PUT
Takeda Pharmaceutical
TAK
$55.5B
| $1.42M | ﹤0.01% |
101,100
-35,400
| -26% | -$505K |
|
|
ONEM
6139
CALL
DELISTED
1Life Healthcare
ONEM
| $1.42M | ﹤0.01% |
181,000
+68,700
| +61% | +$590K |
|
6140
PUT
iShares Russell Mid-Cap Growth ETF
IWP
$21.2B
| $1.42M | ﹤0.01% |
17,900
-80,800
| -82% | -$7.04M |
|
6141
CALL
Gibraltar Industries
ROCK
$1.41B
| $1.42M | ﹤0.01% |
36,600
+7,000
| +24% | +$286K |
|
6142
PUT
Jones Lang LaSalle
JLL
$17B
| $1.42M | ﹤0.01% |
8,100
+500
| +7% | +$99.7K |
|
6143
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$305M
| $1.42M | ﹤0.01% |
+39,123
| New | +$1.53M |
|
6144
CALL
Principal Financial Group
PFG
$24.2B
| $1.42M | ﹤0.01% |
21,200
+3,600
| +20% | +$253K |
|
6145
CALL
10x Genomics
TXG
$7.56B
| $1.42M | ﹤0.01% |
31,300
-35,300
| -53% | -$1.83M |
|
|
CNTA
6146
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.42M | ﹤0.01% |
290,583
-13,843
| -5% | -$88.6K |
|
6147
NovaGold Resources
NG
$3.4B
| $1.42M | ﹤0.01% |
294,278
-258,701
| -47% | -$1.62M |
|
6148
CALL
Sixth Street Specialty
TSLX
$1.75B
| $1.41M | ﹤0.01% |
76,400
+31,900
| +72% | +$675K |
|
6149
CALL
AquaBounty Technologies
AQB
$7.21M
| $1.41M | ﹤0.01% |
41,275
+37,690
| +1,051% | +$1.15M |
|
6150
BayCom
BCML
$334M
| $1.41M | ﹤0.01% |
68,304
+51,369
| +303% | +$1.13M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.